Effect of Teriflunomide (Aubagio®) on Cortico-Basal Ganglionic-Thalamo-Cortical Gray Matter Connectivity in Mouse Model of Multiple Sclerosis (P5.312)


Journal article


C. Modica, F. Schweser, N. Bertolino, T. Rudra, Michelle L. Sudyn, M. Dwyer, R. Zivadinov
2016

Semantic Scholar
Cite

Cite

APA
Modica, C., Schweser, F., Bertolino, N., Rudra, T., Sudyn, M. L., Dwyer, M., & Zivadinov, R. (2016). Effect of Teriflunomide (Aubagio®) on Cortico-Basal Ganglionic-Thalamo-Cortical Gray Matter Connectivity in Mouse Model of Multiple Sclerosis (P5.312).

Chicago/Turabian
Modica, C., F. Schweser, N. Bertolino, T. Rudra, Michelle L. Sudyn, M. Dwyer, and R. Zivadinov. “Effect of Teriflunomide (Aubagio®) on Cortico-Basal Ganglionic-Thalamo-Cortical Gray Matter Connectivity in Mouse Model of Multiple Sclerosis (P5.312)” (2016).

MLA
Modica, C., et al. Effect of Teriflunomide (Aubagio®) on Cortico-Basal Ganglionic-Thalamo-Cortical Gray Matter Connectivity in Mouse Model of Multiple Sclerosis (P5.312). 2016.